PROPANC BIOPHARMA INC Stock Prediction
AI-powered sentiment analysis and prediction trends for PPCB, updated each market day.
PPCB AI Sentiment
AI predicts PROPANC BIOPHARMA INC stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About PROPANC BIOPHARMA INC
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Sector
Exchange
Market Cap
$2,098,425
Cap Tier
Employees
2
Headquarters
CAMBERWELL, VICTORIA, C3
Listed Since
June 15, 2012
Website
PPCB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PPCB Volatility
PROPANC BIOPHARMA INC has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
